000			02034nam a22003615i 4500
001			320853
003			MX-SnUAN
005			20160429161437.0
007			cr nn 008mamaa
008			160111s2015 gw | s |||| 0|eng d
020			_a9783319185187 _9978-3-319-18518-7
035			_avtls000421037
039		9	_y201601110954 _zstaff
050		4	_aQR177
245	1	4	_aThe future of hiv-1 therapeutics : _bresistance is futile? / _cedited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman.
264		1	_aCham : _bSpringer International Publishing : _bSpringer, _c2015.
300			_ax, 254 páginas :
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
490	0		_aCurrent Topics in Microbiology and Immunology, _x0070-217X ; _v389
500			_aSpringer eBooks
505	0		_aHIV Therapy ­ Looking Towards the Future -- Computational challenges of structure-based approaches applied to HIV -- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1 -- HIV-1 integrase multimerization as a therapeutic target -- Targeting HIV transcription: The quest for a functional cure -- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder -- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy -- The Triple Threat of HIV-1 Protease Inhibitors -- Illustrations of the HIV Life Cycle.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700	1		_aTorbett, Bruce E, _eeditor. _9365678
700	1		_aGoodsell, David S, _eeditor. _9160140
700	1		_aRichman, Douglas D, _eeditor. _9365679
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9783319185170
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-319-18518-7 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c320853 _d320853